UnknownPhase 2NCT00754078

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Studying Carcinoma of the anal canal

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AHS Cancer Control Alberta
Principal Investigator
Kurian J Joseph, MD, FRCPC
AHS Cancer Control Alberta
Intervention
Tomotherapy(radiation)
Enrollment
58 enrolled
Eligibility
18 years · All sexes
Timeline
20082016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00754078 on ClinicalTrials.gov

Other trials for Carcinoma of the anal canal

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the anal canal

← Back to all trials